LabCorp Offers At-Home Sample Collection Kit for COVID-19 Test


LabCorp expands availability of at-home sample collection kit for COVID-19 test

Health News Reuters

Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Ramakrishnan M. and Sriraj Kalluvila

(Reuters) – LabCorp said on Tuesday its at-home sample collection kit for COVID-19 testing would now be available to all individuals with symptoms and possible exposure to the virus, after limiting delivery to healthcare workers during its launch last month.

The collection kit, with a list price of $119, consists of cotton swabs to collect nasal specimens, a biohazard specimen bag and a FedEx overnight shipping envelope to mail the samples to labs.

Customers can get the kit with no upfront out-of-pocket costs if they are found to be eligible after filling in a survey on the company’s website, LabCorp said.

The company said it would submit the claim to the individual’s health insurance agency, or the appropriate government program, in case the person does not have insurance.

Read More:

Due to the nature of independent content, VT cannot guarantee content validity.
We ask you to Read Our Content Policy so a clear comprehension of VT's independent non-censored media is understood and given its proper place in the world of news, opinion and media.

All content is owned by author exclusively. Expressed opinions are NOT necessarily the views of VT, other authors, affiliates, advertisers, sponsors, partners or technicians. Some content may be satirical in nature. All images within are full responsibility of author and NOT VT.

About VT - Read Full Policy Notice - Comment Policy